FDA allows licensed pharmacists to prescribe Pfizer’s Paxlovid under certain conditions
By Naomi Thomas, CNN The US Food and Drug Administration revised the emergency use authorization for Pfizer’s Covid-19 antiviral treatment, Paxlovid, on Wednesday to allow state-licensed pharmacists to prescribe the treatment to people who are eligible. “The FDA recognizes the important role pharmacists have played and continue to play in combatting this pandemic,” said Dr.
Continue Reading